Access cutting-edge salivary gland cancer treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access salivary gland cancer specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related salivary gland cancer treatment provided free
The goal of this study is to evaluate the efficacy and safety of Ivonescimab in participants with advanced, metastatic salivary gland cancers. The name of the study drug involved in this study is: -Ivonescimab (a type of antibody)
Sponsor: Glenn J. Hanna
Check if you qualify for this salivary gland cancer clinical trial in Boston, MA
If you're searching for salivary gland cancer treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced salivary gland cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.